Perspectives on nano-nutraceuticals to manage pre and post COVID-19 infections
Article
Dubey, AK, Chaudhry, SK, Singh, HB et al. (2022). Perspectives on nano-nutraceuticals to manage pre and post COVID-19 infections
. 33 10.1016/j.btre.2022.e00712
Dubey, AK, Chaudhry, SK, Singh, HB et al. (2022). Perspectives on nano-nutraceuticals to manage pre and post COVID-19 infections
. 33 10.1016/j.btre.2022.e00712
Optimized therapeutic bio-compounds supported by bio-acceptable nanosystems (i.e., precise nanomedicine) have ability to promote health via maintaining body structure, organ function, and controlling chronic and acute effects. Therefore, nano-nutraceuticals (designed to neutralize virus, inhibit virus bindings with receptors, and support immunity) utilization can manage COVID-19 pre/post-infection effects. To explore these approaches well, our mini-review explores optimized bio-active compounds, their ability to influence SARS-CoV-2 infection, improvement in performance supported by precise nanomedicine approach, and challenges along with prospects. Such optimized pharmacologically relevant therapeutic cargo not only affect SARS-CoV-2 but will support other organs which show functional alternation due to SARS-CoV-2 for example, neurological functions. Hence, coupling the nutraceuticals with the nano-pharmacology perspective of higher efficacy via targeted delivery action can pave a novel way for health experts to plan future research needed to manage post COVID-19 infection effect where a longer efficacy with no side-effects is a key requirement.
